Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration?Allergan's patent for latisse expired?Dabrafenib btd date 2023?What are the most memorable drug brands in oral factor b inhibitors? in united statesXenazine current manufacturer 2025?
See the DrugPatentWatch profile for movantik
Movantik is used to treat opioid-induced constipation (OIC) in adults. Specifically, it helps relieve constipation that happens as a side effect of opioid pain medicines when opioids are still being used for pain [1].
Yes. Movantik is intended for opioid-induced constipation. It is not a general constipation medicine for non-opioid causes [1].
Movantik contains naloxegol, which is designed to counteract constipation caused by opioids in the gut while not reducing pain control in a meaningful way [1].
Patients and caregivers typically look for Movantik when an opioid for pain causes ongoing constipation despite other measures, and they need a medication specifically aimed at opioid-related bowel slowing [1].
Other Questions About Movantik :